Nelfinavir is an orally administered drug that belongs to a treatment classification called protease inhibitors. Preclinical data suggests that Nelfinavir may overcome resistance to proteasome inhibitors in multiple myeloma.
| SparkCures ID | 323 |
|---|---|
| Brand Name | Viracept® |
| Generic Name | Nelfinavir |
| Treatment Classifications |